The paper “ Implications of Type 1 Diabetes-Long Term Condition on a Patient’ s Life Journey and Wellbeing” is a forceful example of a finance & accounting case study. Type 1 diabetes constitutes 5-15% of 285 million adults with diabetes. The disease is increasing at 3% annually, particularly in white Europeans, including northern Europe (Hovorka et al 2011). It accounts for almost 57000 death every year among under 75years, the most intensive users of high-cost services (DoH, 2008). As one of the diseases associated with long-term conditions, type 1 diabetes is a global concern.
Approximately 17.5 million people have a long-term condition (Margereson and Trenoweth, 2010). In Britain, six out of ten adults have a long-term condition that can’ t be cured thus making their care and management even more complex (Chronic disease management, 2004). The aim of this paper is to present a detailed discussion on the implications of a Type 1 diabetes long-term condition on a patient’ s life journey and wellbeing with the use of a case study of a patient suffering from the disease. Background to LTC-Type 1 diabetesPeople with Type 1 diabetes are generally are not obese and may present initially with diabetic ketoacidosis (DKA).
The distinguishing characteristic of a patient with type 1 diabetes is that if his or her insulin is withdrawn, ketosis and eventually ketoacidosis develop. Therefore, these patients are dependent on exogenous insulin which calls for a multidisciplinary approach by physician, nurse, and dietitian. At the new onset of type 1 diabetes, permanent insulin therapy has to be started. There is also need for a long-term medical attention both to limit the development of its devastating complications and to manage them when they do occur.
Type 1 diabetes is an autoimmune disease that results when the body’ s system for fighting infection— the immune system— turns against a part of the body. In this case, the immune system attacks and destroys the insulin-producing beta cells in the pancreas (Devendra, 2004). It is related to premature beta-cell failure or pancreatic beta-cell destruction where the patients completely lack insulin secretion leading to increased blood and urine glucose or severe metabolic lability and eventually ketoacidosis.
Baqar A. Husaini, Pamela C. Hull, Darren E. Sherkat, Janice S. Emerson, Monica T. Overton, Clinton Craun, Van A. Cain, and Robert S. Levine(2004) Diabetes, Depression, and Healthcare Utilization Among African Americans Primary, Care J Natl Med Assoc. 2004; 96:476-484.
Chronic disease management (2004) A compendium of information. London: Department of Health
Devasenan Devendra (2004) Type 1 diabetes: recent developments BMJ 2004; 328:750
Logroscino G, Kang JH, and Gradstein F: Prospective study of type 2diabetes and cognitive decline in women aged 70–81 years.BMJ 328:548, 2004.
Margereson, C. and Trenoweth, S. (eds.) (2010) Developing holistic care for long-term conditions. Oxon: Routledge.
Maurice J O’Kane, Brendan Bunting and Margaret Copeland (2008) Efficacy of self-monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomized controlled trial, British Medical Journal (BMJ) 2008; 336:1174
McAnulty, G. R, Robertshaw H. J. and Hall1 G. M. (2000) Anaesthetic management of patients with diabetes mellitus, Br. J. Anaesth 85 (1): 80-90.
Raha, et al.(2009) Approaches taken in type 1 diabetes research Int J Diab Dev Ctries, April-June 2009 Volume 29 Issue 2 89
Roman Hovorka, et al. (2011) overnight closed-loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: a crossover randomized controlled studies British Medical Journal (BMJ). 2011; 342: d1855